1. Anti-infection Metabolic Enzyme/Protease Apoptosis Membrane Transporter/Ion Channel Neuronal Signaling
  2. Parasite Succinate Dehydrogenase Apoptosis Calcium Channel Mitochondrial Metabolism
  3. Sitamaquine

Sitamaquine (WR 6026) is an orally active Antileishmanial agent and Succinate dehydrogenase inhibitor. Sitamaquine accumulates in the acidocalcisomes of Leishmania, induces organelle alkalization, and crosses the plasma membrane of Leishmania via temperature- and energy-independent diffusion. Sitamaquine disrupts oxidative phosphorylation in Leishmania, induces mitochondrial depolarization, oxidative stress, elevated intracellular calcium, plasma membrane depolarization, and Apoptosis-like cell death. Sitamaquine can be used in the research of leishmaniasis.

For research use only. We do not sell to patients.

Sitamaquine

Sitamaquine Chemical Structure

CAS No. : 57695-04-2

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of Sitamaquine:

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Sitamaquine (WR 6026) is an orally active Antileishmanial agent and Succinate dehydrogenase inhibitor. Sitamaquine accumulates in the acidocalcisomes of Leishmania, induces organelle alkalization, and crosses the plasma membrane of Leishmania via temperature- and energy-independent diffusion. Sitamaquine disrupts oxidative phosphorylation in Leishmania, induces mitochondrial depolarization, oxidative stress, elevated intracellular calcium, plasma membrane depolarization, and Apoptosis-like cell death. Sitamaquine can be used in the research of leishmaniasis[1][2].

In Vitro

Sitamaquine (1-30 μM; 15 min) displaces the acidotropic probe Lysotracker Green from acidic organelles of Leishmania donovani L82, Leishmania donovani DD8, Leishmania tropica LCR-L39, and Leishmania tropica SAF-K27 promastigotes, confirming it accumulates in these organelles[1].
Sitamaquine (5-200 μM; 0-20 min) causes a fast, irreversible reduction in intracellular ATP levels in Leishmania donovani 3-Luc promastigotes, with a 50% reduction observed at concentrations above 30 μM 10 minutes post-treatment[2].
Sitamaquine (50-100 μM; 15 min) induces mitochondrial membrane depolarization in Leishmania donovani promastigotes, causing a 3.1-fold decrease in Rhodamine 123 accumulation with 100 μM treatment for 15 minutes, and a 3.4-fold decrease in 47% of parasites with 50 μM treatment for 15 minutes[2].
Sitamaquine (10-200 μM; 1 h) inhibits succinate dehydrogenase activity in a mitochondrion-enriched fraction from Leishmania donovani promastigotes in a dose-dependent manner[2].
Sitamaquine (50-100 μM; 1 h) induces phosphatidylserine externalization, a marker of apoptosis-like death, in Leishmania donovani promastigotes at 100 μM for 1 hour, causing a 1.9-fold increase in apoptotic cells relative to controls[2].
Sitamaquine (50-100 μM; 24 h) increases the sub-G1 DNA population, a marker of chromatin fragmentation, in Leishmania donovani promastigotes[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis[2]

Cell Line: Leishmania donovani promastigotes
Concentration: 50, 100 μM
Incubation Time: 1 h
Result: Caused a significant 1.9-fold increase in the percentage of apoptotic (annexin V-positive, propidium iodide-negative) promastigotes (n=3; P<0.02) relative to untreated controls at 100 μM.
Showed no significant difference from controls at 50 μM.

Cell Cycle Analysis[2]

Cell Line: Leishmania donovani promastigotes
Concentration: 50, 100 μM
Incubation Time: 24 h
Result: Increased the sub-G1 DNA population, with 17.8% of parasites treated with 50 μM and 38.3% of parasites treated with 100 μM showing sub-G1 DNA content, compared to 10.7% of untreated controls (n=3; P<0.02).
Molecular Weight

343.52

Formula

C21H33N3O

CAS No.
SMILES

N=1C=CC(=C2C=C(OC)C=C(NCCCCCCN(CC)CC)C12)C

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Sitamaquine
Cat. No.:
HY-19688
Quantity:
MCE Japan Authorized Agent: